On February 13, 2026, Nxera Pharma announced Board changes, nominating Mr. Takeo Morooka as new External Director from its Strategic Advisory Council.2
Ms. Miwa Seki and Mr. Noriaki Nagai will retire from the Board.2
Appointments subject to approval at the 36th Ordinary General Meeting of Shareholders on March 25, 2026.2
Mr. Morooka brings expertise in regulatory affairs and pharmaceutical policy from roles like Founder/CEO of PH Consulting and prior Nxera advisory position.2
Re-appointments include Chris Cargill, David Roblin, Rolf Soderstrom, Naoko Shimura, Nicola Rabson, and Eiko Tomita.2
Chris Cargill, President & CEO, welcomed Morooka for guidance on growth strategy and thanked outgoing directors.2
Sources:
2. https://www.globenewswire.com/news-release/2026/02/13/3237936/0/en/Nxera-Pharma-Proposes-Changes-to-its-Board-of-Directors.html